Cross-border transactions: A roadmap for commercial arrangements between North American and European companies

Author： Fersko Raymond S Merabet Hind Cordioli Valentina

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.11, Iss.1, 2004-10, pp. : 72-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies

By Liikanen Erkki

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 38-43

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

The science of nations: European multinationals and American biotechnology

By Sharp Margaret

International Journal of Biotechnology, Vol. 1, Iss. 1, 2004-05 ,pp. : 132-162

Inderscience Publishers

Access to resources Recommend Favorite

Cross-Seeding Interaction Between Amyloid ? and Tau Protein can Enhance Aggregation

Current Biotechnology, Vol. 6, Iss. 3, 2017-07 ,pp. : 273-279

Bentham Science Publishers

Access to resources Recommend Favorite

Rethinking commercial strategy – A patient-centered commercial model

By Rao Sanjay K

Journal of Commercial Biotechnology, Vol. 16, Iss. 3, 2010-07 ,pp. : 206-223

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Determining the cross‐talk between smooth muscle cells and macrophages on a cobalt‐chromium stent material surface using an in vitro postimplantation coculture model

Journal Of Biomedical Materials Research. Part A, Vol. 106, Iss. 3, 2018-03 ,pp. : 673-685

John Wiley & Sons Inc

Access to resources Recommend Favorite